Neuropathic Pain Drug and Device Pipeline is Focus of MedPredict’s New…

Significant unmet needs remain in pain management – drug and device developers seek to identify mechanisms to maintain efficacy while reducing side effects and risk of opioid dependence.(PRWeb July 29, 2010)Read the full story at http://www.prweb.com/releases/2010/07/prweb4320974.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Message: Register for MedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.

This entry was written by PRWeb: Medical Pharmaceuticals, posted on July 30, 2010 at 10:44 pm, and filed under Uncategorized.